2014
DOI: 10.1111/epi.12793
|View full text |Cite
|
Sign up to set email alerts
|

The Kv1.1 null mouse, a model of sudden unexpected death in epilepsy (SUDEP)

Abstract: The Kv1.1 null mouse is a potential model for SUDEP in patients who experience ictal and postictal bradycardia. It offers the opportunity for evaluation of the combination of factors, in addition to vagal activation, necessary to produce a terminal asystole following seizure. It is notable that long-term studies that evaluate electroencephalography (EEG) and cardiorespiratory events surrounding nonfatal seizures may provide indices predictive of terminal seizure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
73
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(77 citation statements)
references
References 43 publications
(100 reference statements)
3
73
0
Order By: Relevance
“…Previous studies have reported that Kcna1‐ null mice model multiple SUDEP risk factors and terminal events because they have (1) spontaneous seizures and (2) a severe seizure phenotype with myoclonic and generalized tonic–clonic (GTC) seizures (3) that are refractory to traditional antiseizure drugs (e.g., carbamazepine, (Simeone TA, Kim DY, Simeone KA, Rho JM) unpublished data). (4) Kcna1‐ null mice are cognitively impaired and (5) have cardiac arrhythmias; the terminal events associated with their sudden death include (6) a GTC seizure followed by (7) enhanced postictal parasympathetic‐mediated bradyarrhythmias, and (8) asystole and death …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies have reported that Kcna1‐ null mice model multiple SUDEP risk factors and terminal events because they have (1) spontaneous seizures and (2) a severe seizure phenotype with myoclonic and generalized tonic–clonic (GTC) seizures (3) that are refractory to traditional antiseizure drugs (e.g., carbamazepine, (Simeone TA, Kim DY, Simeone KA, Rho JM) unpublished data). (4) Kcna1‐ null mice are cognitively impaired and (5) have cardiac arrhythmias; the terminal events associated with their sudden death include (6) a GTC seizure followed by (7) enhanced postictal parasympathetic‐mediated bradyarrhythmias, and (8) asystole and death …”
Section: Discussionmentioning
confidence: 99%
“…Treatment with the KD has been reported to completely abolish seizures in up to 13% of patients and reduce seizure frequency by >50% in approximately two thirds of patients with refractory epilepsy . We have previously reported that the KD effectively reduces seizures in Kcna1 ‐null mutant mice, which model early onset epilepsy, multiple temporal lobe epilepsy syndromes , and SUDEP . Due to the broad‐spectrum efficacy of KD in controlling seizures, in the current study we asked whether KD treatment can increase longevity in Kcna1 ‐null mice.…”
mentioning
confidence: 95%
“…Overlapping neuronal and cardiac expression patterns of mutant ion channels are proposed to underlie the pathophysiology of a number of genetic diseases that exhibit both epilepsy and cardiac arrhythmia. In addition to mutations in genes encoding VGSC α-and β-subunits, mutations in the neurocardiac potassium channel genes KCNA1 (46,47), KCNH2 (48-51), KCNQ1 (52), and KCNT1 (53) as well as HCN1 (54,55) have been linked to SUDEP. Mutations in genes encoding proteins that modify ion channels in brain and heart, such as SENP-2, also lead to SUDEP in animal models (56).…”
mentioning
confidence: 99%
“…In the K V 1.1-null mouse model, postictal bradyarrhythmias have been shown to immediately precede death. 17,18 Aberrant parasympathetic neurotransmission is partly to blame for these cardiac events. Enhanced parasympathetic effects on heart causing interictal and postictal bradycardia were also identified as the immediate antecedents to SUDEP in heterozygous Na V 1.1 knockout mice, a model of the epileptic encephalopathy Dravet syndrome.…”
Section: Circ Arrhythm Electrophysiolmentioning
confidence: 99%